Back
Protagonist Therapeutics Stock Price Chart
10 Best Stocks to Own in 2025
Get your copy now FREE!
Sell
50
PTGX
Protagonist Therapeutics
Last Price:
$47.47
Seasonality Move:
28.19%
7 Day Trial
ALL ACCESS PASS
$
7
10 stocks to buy for the next leg of this rally
Get the full list here FREE-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Protagonist Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.17 | Buy |
| 20-day SMA: | 44.92 | Buy |
| 50-day SMA: | 46.04 | Buy |
| 200-day SMA: | 43.19 | Buy |
| 8-day EMA: | 46.09 | Buy |
| 20-day EMA: | 45.47 | Buy |
| 50-day EMA: | 45.05 | Buy |
| 200-day EMA: | 41.62 | Buy |
Protagonist Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.38 | Buy |
| Relative Strength Index (14 RSI): | 59.14 | Buy |
| Chaikin Money Flow: | 645119 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.72 - 46.16) | Buy |
| Bollinger Bands (100): | (37.47 - 48.59) | Buy |
Protagonist Therapeutics Technical Analysis
| May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 15 | 16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Protagonist Therapeutics Stock
Is Protagonist Therapeutics Stock a Buy?
-
Protagonist Therapeutics share price is 47.58 while PTGX 8-day simple moving average is 46.17, which is a Buy signal.
-
The stock price of PTGX is 47.58 while Protagonist Therapeutics 20-day SMA is 44.92, which makes it a Buy.
-
Protagonist Therapeutics 50-day simple moving average is 46.04 while PTGX share price is 47.58, making it a Buy technically.
-
PTGX stock price is 47.58 and Protagonist Therapeutics 200-day simple moving average is 43.19, creating a Buy signal.
PTGX Technical Analysis vs Fundamental Analysis
Sell
50
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics a Buy or a Sell?
-
Protagonist Therapeutics stock is rated a SellThe current Protagonist Therapeutics [PTGX] share price is $47.58. The Score for PTGX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Protagonist Therapeutics Stock Info
Market Cap:
2.9B
Price in USD:
47.58
Share Volume:
688.5K
Protagonist Therapeutics 52-Week Range
52-Week High:
60.60
52-Week Low:
27.00
Sell
50
Protagonist Therapeutics (PTGX)
is a Sell
Protagonist Therapeutics Share Price Forecast
-
What is the Protagonist Therapeutics stock price today?The Protagonist Therapeutics stock price is 47.58 USD today.
-
Will PTGX stock go up or go down?Protagonist Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Protagonist Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protagonist Therapeutics is overvalued.
Is Protagonist Therapeutics Stock a Buy?
-
Protagonist Therapeutics share price is 47.58 while PTGX 8-day exponential moving average is 46.09, which is a Buy signal.
-
The stock price of PTGX is 47.58 while Protagonist Therapeutics 20-day EMA is 45.47, which makes it a Buy.
-
Protagonist Therapeutics 50-day exponential moving average is 45.05 while PTGX share price is 47.58, making it a Buy technically.
-
PTGX stock price is 47.58 and Protagonist Therapeutics 200-day simple moving average is 41.62, creating a Buy signal.
Fundamental Analysis of Protagonist Therapeutics
Is Protagonist Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.13 per share, a decrease this year of $4.12 per share, and an increase next year of $0.45 per share.
Technical Analysis of Protagonist Therapeutics
Should I short Protagonist Therapeutics stock?
-
PTGX Moving Average Covergence Divergence (MACD) indicator is 0.38, suggesting Protagonist Therapeutics is a Buy
-
Protagonist Therapeutics Relative Strength Index (RSI) is 59.14, which suggest Protagonist Therapeutics is overbought
-
The Bollinger Bands (25) for Protagonist Therapeutics is (43.72 - 46.16), which suggest Protagonist Therapeutics is a Buy
-
The Bollinger Bands (100) for Protagonist Therapeutics is (37.47 - 48.59), which suggest Protagonist Therapeutics is a Buy
* Protagonist Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.